04/28/2025 12:00
Alnylam Receives Positive CHMP Opinion for Vutrisiran for the Treatment of ATTR Amyloidosis with Cardiomyopathy

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNA interference (RNAi) therapeutics company, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending approval of its RNAi therapeutic vutrisiran for the treatment of wild type or hereditary transthyretin amyloidosis in adult patients with cardiomyopathy (ATTR-CM). ATTR-CM is a debilitating, rapidly progressive and potentially fatal ...

04/28/2025 12:00
HistoSonics’ Histotripsy System Demonstrates 90% Local Tumor Control at 12 Months in #HOPE4LIVER Trials

HistoSonics, the developer of the Edison Histotripsy System, announced today 12-month follow-up clinical data from its prospective #HOPE4LIVER trials, designed to evaluate the safety and efficacy of histotripsy for the non-invasive destruction of primary (hepatocellular cancer-HCC) and metastatic liver tumors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250428931117/en/ The Edison System, which received U.S. Food and Drug Administ...

06/04/2025 05:10
KATE, Japan’s No. 1 Makeup Brand, Launches Strategic Initiatives to Strengthen Business and Brand Recognition Across Asia

Kao Corporation (TOKYO:4452) has identified its international makeup brand KATE as a strategic growth driver within its cosmetics portfolio. This initiative aligns with the company’s ambition to establish a “Global Sharp Top” business framework. In line with this vision, Kao is making significant investments to amplify KATE’s global presence. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250603453681/e...

04/28/2025 12:15
Philip Morris International CEO Jacek Olczak Addresses Emerging Global Divide in Regulatory Approaches to Consumer Innovation

Jacek Olczak, Chief Executive Officer of Philip Morris International Inc. (NYSE: PM), outlined the need for common-sense regulations in the consumer goods sector while addressing global leaders at Semafor’s annual World Economy Summit in Washington, D.C., on April 25, 2025. Olczak emphasized the sector’s potential for innovation-led growth despite the volatile economic environment. He stressed, however, that without appropriate regulation and policy frameworks to enable scientific evaluation an...

AFP holds online workshop on verifying climate disinformation ahead of COP30 in Brazil

AFP held a digital investigation workshop on Wednesday 12 February for Brazilian journalists preparing to cover the COP30 – the 30th session of the UN climate change conference –, to be held in November 2025 in the Amazon, in the city of Belém.

AFP held a digital investigation workshop on Wednesday 12 February for Brazilian journalists preparing to cover the COP30 – the 30th session of the UN climate change conference –, to be held in November 2025 in the Amazon, in the city of Belém.
04/23/2025 17:29
CORRECTING and REPLACING Saviynt Hires Identity Veteran Roger Hsu to Accelerate Asia Growth

Headline of release issued April 22, 2025, at 9:30 p.m. PT/April 23, 2025, at 12:30 a.m. ET should read: Saviynt Hires Identity Veteran Roger Hsu to Accelerate Asia Growth (instead of Saviynt Hires Former SailPoint ASEAN Leader Roger Hsu to Accelerate Asia Growth). The updated release reads: SAVIYNT HIRES IDENTITY VETERAN ROGER HSU TO ACCELERATE ASIA GROWTH Appointment of cybersecurity veteran underscores Saviynt’s commitment to identity security amid rising threats and rapid growth across A...

04/28/2025 12:30
Mainstay Medical Announces Exclusive Coverage of ReActiv8® by Anthem Blue Cross/Blue Shield

Mainstay Medical Holdings plc today announced that Anthem Blue Cross and Blue Shield (“Anthem”) has established favorable coverage for the company’s ReActiv8 Restorative NeurostimulationTM therapy for the treatment of intractable chronic low back pain. ReActiv8 is the only therapy considered medically necessary by the policy when the conditions for coverage are met. The coverage went into effect on April 16, 2025, and expands access to the procedure, when clinically appropriate, to Anthem’s pol...

Mehdi Lebouachera appointed AFP’s next Global Editor-In-Chief

Mehdi Lebouachera has been appointed as AFP’s next Global Editor-In-Chief, replacing Sophie Huet, who is taking on a new role developing the agency’s Artificial Intelligence strategy.

Mehdi Lebouachera has been appointed as AFP’s next Global Editor-In-Chief, replacing Sophie Huet, who is taking on a new role developing the agency’s Artificial Intelligence strategy.
Anglais
06/04/2025 05:57
CertiCon, an HTEC Company, Honored With Supplier Award 2024 by Frequentis for Outstanding Performance and Sustainability

CertiCon, a high-tech engineering company and part of the HTEC Group, has been awarded the prestigious Supplier Award 2024 by Frequentis, a global leader in communication and information systems for safety-critical applications. This marks the second consecutive year that CertiCon has been recognized as one of the three Frequentis’s top-performing suppliers. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/...